← Human Trials & Peer-Reviewed Studies
Oxytocin discontinuation during active labor in women who undergo labor induction
Plain-language guide to PMID 22989707 (2012): randomized controlled trial study of Oxytocin.
Key Facts
- PMID
- 22989707
- Journal
- American journal of obstetrics and gynecology
- Year
- 2012
- Study type
- Randomized Controlled Trial
- Authors
- Diven LC et al. (6 authors)
- DOI
- 10.1016/j.ajog.2012.08.035
- Registered trial
- NCT00957593
What This Study Did, in Plain Language
What Was Tested
This randomized controlled trial paper looks at Oxytocin.
Who Took Part
The age groups tagged for this paper are young adults and adults, women only.
The researchers conducted a prospective randomized controlled trial of women who underwent induction of labor at term; they were assigned randomly to either routine oxytocin use (routine) or oxytocin discontinuation (DC) once in active labor.
How the Study Was Run
In design terms this was a randomized study.
The participants were allocated by chance, so the Oxytocin group and the comparison group should start out alike.
Analysis was by intention to treat.
What Was Measured
PubMed files the paper under topics including Cesarean Section, Chorioamnionitis, Labor Onset, Labor, Induced, Labor, Obstetric, Oxytocics and Oxytocin.
What This Means in Plain Language
The paper is a randomized study of Oxytocin.
Its findings take up roughly 5 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2012 (American journal of obstetrics and gynecology), a journal based in United States.
More context: the Oxytocin compound page, all human trials.
Our Notes on the Compound
Oxytocin: A peptide hormone with established obstetric medical uses and a less settled role in research on behavior, sexual function and appetite.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.